CYLERT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cylert, and when can generic versions of Cylert launch?
Cylert is a drug marketed by Abbott and is included in two NDAs.
The generic ingredient in CYLERT is pemoline. There are seven drug master file entries for this compound. Additional details are available on the pemoline profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CYLERT?
- What are the global sales for CYLERT?
- What is Average Wholesale Price for CYLERT?
Summary for CYLERT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 45 |
| Patent Applications: | 3,595 |
| DailyMed Link: | CYLERT at DailyMed |
US Patents and Regulatory Information for CYLERT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbott | CYLERT | pemoline | TABLET, CHEWABLE;ORAL | 017703-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbott | CYLERT | pemoline | TABLET;ORAL | 016832-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbott | CYLERT | pemoline | TABLET;ORAL | 016832-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbott | CYLERT | pemoline | TABLET;ORAL | 016832-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
